Atea Pharmaceuticals: Early Stage Developer Of Oral Small Molecule SARS-CoV-2 Therapy (NASDAQ:AVIR)

1970-01-01T00:00:00-05:00January 1st, 1970|

share this article!

Atea has a major deal with Roche. Atea just IPO-ed, but it already has $4.4bn in market cap. Read More

share this article!